Literature DB >> 7508575

Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity.

F Vallebuona1, M Raiteri.   

Abstract

The nitric oxide synthase/cyclic GMP pathway has been studied in vivo in the adult rat cerebellum by monitoring the levels of extracellular cyclic GMP during microdialysis in conscious unrestrained animals. The basal cyclic GMP efflux was concentration-dependently reduced upon local infusion of the nitric oxide synthase inhibitor NG-nitro-L-arginine (10 microM-1 mM). The nitric oxide donor S-nitroso-N-penicillamine, perfused through the dialysis probe at 1 mM, increased by about 200% the extracellular levels of cyclic GMP. The glutamate receptor agonist N-methyl-D-aspartate (500 microM) produced a cyclic GMP response which was abolished by the selective receptor antagonist D-2-amino-5-phosphonovaleric acid (500 microM) or by NG-nitro-L-arginine (10 microM). The elevation of cyclic GMP levels caused by local infusion of 500 microM N-methyl-D-aspartate was also abolished by parenteral administration of the N-methyl-D-aspartate channel blocker dizocilpine (0.4 mg/kg, i.p.). Local perfusion of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (1 mM) increased by about 150% the extracellular levels of cyclic GMP. It is concluded that cyclic GMP collected during in vivo microdialysis reflects nitric oxide synthase activity in the rat cerebellum. The technique may be utilized to investigate the pathophysiology and the pharmacology of the nitric oxide/cyclic GMP pathway in the cerebellum of living animals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508575     DOI: 10.1016/0306-4522(93)90007-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.

Authors:  E Fedele; Y Jin; G Varnier; M Raiteri
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: an in vivo cyclic GMP microdialysis study in rat cerebellum.

Authors:  E Fedele; M Raiteri
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  In vivo NO/cGMP signalling in the hippocampus.

Authors:  E Fedele; M Marchi; M Raiteri
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  Ascorbic acid acts as an inhibitory transmitter in the hypothalamus to inhibit stimulated luteinizing hormone-releasing hormone release by scavenging nitric oxide.

Authors:  S Karanth; W H Yu; A Walczewska; C Mastronardi; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

5.  Ectocellular in vitro and in vivo metabolism of cADP-ribose in cerebellum.

Authors:  A De Flora; L Guida; L Franco; E Zocchi; M Pestarino; C Usai; C Marchetti; E Fedele; G Fontana; M Raiteri
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.